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T-cell memory to pathogens can be envisioned as a receptor-based imprint of the
pathogenic environment on the naïve repertoire of clonotypes. Recurrent exposures to a
pathogen inform and reinforce memory, leading to a mature state. The complexity and
temporal stability of this system in man is only beginning to be adequately described.
We have been using a rank-frequency approach for quantitative analysis of CD8T
cell repertoires. Rank acts as a proxy for previous expansion, and rank-frequency,
the number of clonotypes at a particular rank, as a proxy for abundance, with the
relation of the two estimating the diversity of the system. Previous analyses of circulating
antigen-experienced cytotoxic CD8 T-cell repertoires from adults have shown a complex
two-component clonotype distribution. Here we show this is also the case for circulating
CD8T cells expressing the BV19 receptor chain from five adult subjects. When the
repertoire characteristic of clonotype stability is added to the analysis, an inverse
correlation between clonotype rank frequency and stability is observed. Clonotypes
making up the second distributional component are stable; indicating that the circulation
can be a depot of selected clonotypes. Temporal repertoire dynamics was further
examined for influenza-specific T cells from children, middle-aged, and older adults.
Taken together, these analyses describe a dynamic process of system development and
aging, with increasing distributional complexity, leading to a stable circulating component,
followed by loss of both complexity and stability.
Keywords: human CD8 T cells, computational immunology, repertoire maturation, circulation as depot,
senescence
INTRODUCTION
Adaptive immune memory to pathogens arises by selecting particular lymphocyte clones from
a pre-existing repertoire of naïve cells whose clonal antigen receptor has sufficient avidity to
recognize the pathogen and initiate a response. Naïve lymphocytes show a high degree of species
richness owing to the somatic rearrangement undergone by their antigen-specific receptor genes
during their thymic development. Limited expansion of the thymocytes results in a relatively
uniform naïve T cell frequency distribution, hence overall low diversity. Naïve cells are selected
on pathogen in the periphery, and a portion of the expanded antigen-experienced cells are retained
to guard against exposure to the same or similar pathogens. The original recruitment of adaptive
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immunity in a response to pathogen is based on antigen
presentation by innate immune cells that are primary responders
and which play a predominant role in clearing the first exposure.
Upon re-exposure by the same or similar pathogen, immature
adaptive memory will still be augmented by an innate
inflammatory response, which will constitute the signal for
continuing maturation of the adaptive system. Mature functional
adaptive memory can be defined as the point when the innate
cells are primarily required the antigen presentation and not
the inflammatory response. This maturation process may require
multiple exposures or immunizations against some pathogens.
An early elegant description of the maturation process for
B cells came from the work of Berek and co-authors, who
showed the appearance of new, mutated IgH genes encoding high
affinity antibodies only after multiple immunizations to the same
antigen (1, 2).
T cell responses do not undergo the mutational maturation as
do B cell responses and the primary evidence for maturation is
the expansion in the number of cells involved in the response.
Antigen experienced T cells are characterized by differential
expression of activation and homing molecules (3). Further
studies have established concepts such as effector vs. central
memory (4, 5) and importantly the movement of memory T cells
into depots and tissues (6–8). Analyses of immune and tissue
depots have been recently described in man (9, 10). Memory
maturation in humans has the added dimension of thymic
involution (11) at puberty, which limits the number of new
clonotypes that can enter the adult memory pool (12).
Our studies of the CD8 memory T cell repertoire take
advantage of cellular expansion. The precursor frequency of
the cells in the circulation is increased after expansion and the
cells continue to show a strong replicative/survival response
in culture when stimulated by a pathogen-derived peptide
epitope. The latter can be considered as an additional in vitro
exposure. Our focus has been on the CD8T cell response to
the conserved, matrix-derived, influenza epitope, M158−66. In
individuals positive for human leukocyte antigen A2 (HLA-A2),
this peptide drives a complex recall response. The distribution of
the cells can be described as composed of two components when
analyzed by rank frequency analysis (13). The first component
is power law-like and the second component is composed of
higher-ranking clones with typically only one exemplar per
rank. The repertoire is characterized by use of the TRBV19
gene (hereafter referred to as BV19) which encodes Arg and
Ser as part of the non-germ line component of the third
complementarity determining region (CDR3) of the receptor
(14–16). The CDR3 length is 11 amino acids and the RS appears
at position 5. We have shown that the same complex clonotype
distribution holds whether the cultures are further subdivided
by their cytotoxicity, cytokine secretion, or binding of major
histocompatibility complex (MHC)-bound antigen multimers
(17). We have also shown that the distribution of the two
components changes between middle-aged and older subjects
(18). Recently, we have shown that the entire circulating CD8
BV19 repertoire, which subsumes the flu-specific repertoire,
shows the same two component rank-frequency distribution as
observed in the recall repertoire (19).
The first, power law-like, component of the distribution
reflects the action of a repeated birth-death selection process
(20, 21). It can also be viewed as affinity-based selection for
replication of a set of cells that are initially normally distributed
with respect to affinity for a ligand (13). The second component
of the MI58−66-specific and BV19-specific repertoires has posed
a puzzle as to its significance. It could represent a secondary
selective expansion process. However, a simpler explanation is
that the second component reflects a differential abundance of
well-selected clonotypes in the circulation. We therefore expect
that such clonotypes, in addition to being sampled at higher than
expected frequencies, will be stable over time.We also expect that
the second component will be a function of age as it is unlikely a
stable repertoire component can precede the establishment of the
initial complex repertoire.
Here we use a measure of clonotype stability of circulating
BV19 clonotypes from five adult subjects to show that the second
distributional component is indeed stable. We then go in to
show the same relation can be observed for recall repertoires.
Furthermore, the circulating stable component is not observed
in children, and is present in a degraded form in older adults.
The results are discussed in terms of repertoire development and




Peripheral blood mononuclear cells (PBMC) were collected from
five healthy child subjects (C1, C2, C3, C4, and C5), six healthy
middle-aged adult subjects (mA1, mA2, mA3, mA4, mA5, and
mA6) and six older adult subjects (oA1, oA2, oA3, oA4, oA5,
and oA6). All subjects were typed as HLA-A2.1-positive. Ages
at time of enrollment, number of blood samples and average
time span between samples for the ex vivo sequencing and
in vitro recall studies are provided in Table 1. The timing
of sample collection relative to the date of first sampling is
provided in Supplemental Table 1 and illustrates the spacing
between individual measurements and general overlap across
study subjects. This timing data shows that our estimates of
stability are derived under similar conditions for each person.
Because we are interested in steady state conditions, samples were
used from time periods during which the subjects did not report
flu-like illness since the previous sampling. A subset of adult
subjects performed bi-weekly self-administered swabs during the
local the flu season. The samples used here were not taken from
samples collected after a swab positive for influenza.
The healthy child subjects were enrolled under protocol
Children’s Hospital of Wisconsin IRBnet: 116305 “Generation
and decay of memory T cells in children with Juvenile
Rheumatoid Arthritis and healthy siblings following
administration of trivalent inactivated influenza vaccine,”
from the Children Hospital of Wisconsin. The subjects analyzed
here were the controls in this study. The adult subjects were
enrolled under protocols authorized by the Institutional Review
Board of BloodCenter of Wisconsin: BC 05-11, “Generation and
Decay of Memory T Cells in Older Populations,” and BC 04-22,
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TABLE 1 | Age and sample collection data of the study cohorts.











Adults oA1 68 6 3.77
mA1 39 7 2.94
mA2 40 6 3.31
mA3 40 5 2.55
mA4 44 6 3.37
Average§ 46.20 ± 12.34 6.00 ± 0.71 3.19 ± 0.46
Recall Children C1 7 8 3.79
C2 9 5 7.98
C3 10 6 3.77
C4 12 8 3.79
C5 14 7 3.79




mA1 39 10 2.65
mA2 40 8 3.44
mA5 40 8 2.49
mA6 48 10 4.43
Average 41.75 ± 4.19 9.00 ± 1.15 3.25 ± 0.89
Older
adults
oA1 68 8 1.94
oA2 78 8 5.69
oA3 69 9 3.56
oA4 78 13 3.81
oA5 80 5 5.36
oA6 78 8 4.56
Average 75.13 ± 5.23 8.50 ± 2.59 4.15 ± 1.37
§ Indicates mean ± standard deviation.
“Robust T Cell Immunity to Influenza in Human Populations.”
These protocols have been transferred to the IRB of the Medical
College of Wisconsin (MCW). Written informed consent was
obtained from participants, or their parents/legal guardians in
the case of children.
M158−66 Recall Culture and Clonotyping
PBMC were isolated using Ficoll-Paque plus (Amersham
Biosciences) and stored frozen under liquid N2 until used. The
M158−66 peptide (GILGFVFTL) from theM1 protein of influenza
A virus was synthesized by The Blood Research Institute Peptide
Core. The procedure for the culturing PBMC, CD8 cell selection,
nucleic acid preparation, amplification, cloning, and sequencing
has been described previously (17). The recall analyses were
performed as part of our general human immunology studies.
PBMC were stimulated at 1 × 106 cell/ml in 2-ml cultures with
M158−66 peptide added to 1µM final concentration in complete
RPMImedia supplemented 10 U/ml of recombinant IL2 and 10%
human pooled AB sera in round bottom tubes or wells for 7 days.
On day 3, an IL2 supplement (10 U/ml) was provided. On day 7
non-adherent cells were collects after agitation, counted and re-
plated with an equivalent number of fresh irradiated autologous
PBMC at 106 cells/ml. The feeders had been prepulsed with
peptide (1µM final concentration). IL2 was added to 10 U/ml.
Another 7-day culture was performed with IL2 addition at day 3.
However, the analysis for subject mA6, and for most of the child
samples was performed with our dendritic cells (DC) protocol
in which adherent cells are prepared by overnight culture. Half of
these adherent cells (monocyte derived APC) are used for the first
week stimulation of the non-adherent PBMC (i.e., lymphocytes),
and the other half maintained in IL4 and GM-CSF for use in
the second week. All cultures in adults were in triplicate, and
predominantly in duplicate for the child cohort owing to smaller
blood sample volumes.
After two 7-day cycles of recall culture, CD8 cells are isolated
by magnetic beading using Dynal CD8 positive isolation kit
(Invitrogen Inc., Carlsbad, CA) according to manufacturer’s
instruction. mRNA samples were isolated from the CD8 cells
using Dynal Oligo (dT) beads according to manufacturer’s
instructions (Invitrogen). cDNAs was prepared using a poly-T
primer andMMLV reverse transcriptase (Invitrogen). All cDNAs
were titrated using a pair of C-region primers, one labeled with
fluorescein, in three PCR reactions for 20 cycles, each reaction
using a doubling of the cDNA concentration. The cDNA for
BV19 analysis was used at the concentration corresponding to the
midpoint in the linear plot of cDNA concentration to amplicon
fluorescence intensity using cDNA concentrations where the
amplicon fluorescent intensity increased in direct relation to
the cDNA concentration. The PCR used our standard BV19
and BC primers (22). The BV19 primer concentration was 20
times the concentration of the C-region primers used in the
titration to ensure the same efficiency. As long as the experiments
are performed under these conditions, they should provide
representative data about the sample. Since all samples obtained
from humans are far from exhaustive, representative data is all
that can be expected.
We chose CD8 selection after having examined the outcomes
of separating the cells based on CD107 expression as a marker
for degranulation/cytotoxicity function and M158−66:HLA-A2
multimers as a TCR affinity marker. We observed that each of
these showed a complex repertoire, but they were not completely
overlapping. Hence CD8 represented the broadest selection and
was the simplest to use as well (17), which is important when large
number of samples are involved.
The PCR product was cloned into E. coli using pCR4-
TOPOCloning Kit (Invitrogen, Carlsbad, CA). Bacterial colonies
(∼400) were grown overnight and sent to Agencourt Bioscience
(Beverly, MA) for sequencing. Sequences were received in
fasta format and analyzed using “CDR3Reader” software, which
identified V and J regions, assigns clonotype names according to
our convention (23), and counts occurrences of each clonotype.
The identity of a distinct instance of a β-chain is based
on the rearrangement site with respect to each of the two
rearrangements that generated the chain, D to J and V to DJ. The
region between the sites is referred to as the NDN region which
represents the junctional diversity present in all the β-chain genes
that underwent the same D to J and V to DJ choice. The NDN
region is embedded in the CDR3 (24), which is composed of all
the amino acids between the conserved cysteine at the c-terminus
of the V gene and the conserved phenylalanine-glycine in the J
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region. The naming convention provides the information as to
which V and J regions were used, the sequence and encoding of
the NDN as well as the length of the CDR3.
Data analyzed represents pooling of the duplicate and
triplicate cultures. Although the colony counting procedure
involves ligation and bacterial transformation steps, the results
are reproducible as tested in experiments in which large
cultures were divided in three and each portion subject to
CD8 selection, bacterial cloning and sequencing. There was an
excellent clonotype overlap between the three separate assays of
the same culture [Supplemental Figure 1 in (17)].
It should be pointed out that our definition of clonotype is
only based on the TCR β-chain. Most T cells only express one β-
chain, referred to as allelic exclusion, so this is a close one to one
mapping. However, after thymic β-selection, the DN thymocytes
expand prior to α-chain gene rearrangement (25, 26). Thus, cells
with the same β-chain may have different α-chain partners, with
cells with each distinct β-α pair representing a separate clonotypic
lineage. Thus, our description of diversity is an underestimate, as
our analysis would group all of these as one lineage.
High Throughput Sequencing (HTS) of
BV19 TCR
T cell sequence analysis is described in more detail elsewhere
(19, 27), including error estimation, and steps taken in
cleaning the nucleotide sequence data, defining motifs and motif
distributions. In brief, PBMC from five to seven different time
points per subject were used (Table 1, ex vivo HTS panel).
PBMC were thawed, CD8 cells collected by magnetic bead
separation and mRNA and cDNA prepared as described above.
PCR amplification was done using our standard BV19 and BC
primers modified to include the Roche 454 adapter sequences
and sample ID tag sequences. Owing to the higher concentrations
needed for 454 sequencing in lieu of scaling up, multiple
amplifications were performed, each equivalent to the reactions
used for the cultures. The concentration of purified PCR products
was measured using NanoDrop-1000 spectrophotometer. From
6 to 12 purified PCR products were pooled to obtain a total
of 2,500 ng. The samples were further amplified and prepared
for high throughput sequencing at the Human and Molecular
Genomic Center (HMGC) Sequencing Facility (www.hmgc.mcw.
edu) of Medical College of Wisconsin. The sequencing was
performed on the Roche GS-FLX Genome Sequencer using
Titanium chemistry. Samples were coded by identifier sequences
embedded in the primers. After decoding, sequences derived
from each sample were downloaded in fasta format and analyzed
using “CDR3Reader.”
The HTS data differs from the recall data in the presence
of two power law-like components in the rank-frequency
analyses. The method used did not include a unique molecular
identifier as part of the cDNA or second strand synthesis (28).
With the additional amplification associated with Roche 454
sequencing it is very likely that the shift to higher ranks of
the second component is associated with the concentration of
cDNA (sample) being analyzed and the number of amplification
cycles. Decreasing the concentration of cDNA under identical
experimental conditions enhances the shift (unpublished),
thus our analyses were restricted to using sufficiently high
concentrations of cDNA that minimized this effect. This implies
starting with a sample size sufficient to clearly observe the
lower ranks.
Data Analysis
The repertoire data from any sample can be tabulated as
the clonotype name and the number of observations of that
clonotype. Data from such a table can be used to define some
key repertoire measures: number of clonotypes, N, number
of observations, M, number of clonotypes observed once (i.e.,
singletons), NS , the highest ranking clonotype, Rmax. Rank
frequency analysis involves counting the number of clonotypes
observed once, twice, thrice, to Rmax. These measures in turn
can be used to generate a number of repertoire characteristics.
We use: (1)N as a general proxy for richness, (2) MN , observations
per clonotype as a proxy for abundance, (3) NsN , the fraction
of clonotypes observed once (i.e., rank = 1) to describe the
singleton tail of the distribution, and (4) RmaxM , the proportion
of observations due to the highest ranking (i.e., most frequently
observed) clonotype. These four characteristics offer a general
overview of the distribution as they provide an average richness
and abundance and a description of the two extremes.
We used a similar approach to clonotype temporal stability
within the repertoire. The stability of the clonotype is defined
as the number of times it was observed across repeated
measurements. Clonotypes observed at all times analyzed are
considered stable and clonotypes observed only at one time
unstable. Because the measurement of temporal stability is based
on multiple time points, more time points should provide a
better estimation of stability. To compensate for small differences
in the number of time points, we introduce a relative stability
characteristic of the repertoire in which observation at one time
is equal to a stability of 0, observation at all times is equal to a
relative stability of 1. Thus, the relative stability of a clonotype
is calculated as:
number of times observed − 1
maximum possible number of times observed − 1
. The
average relative stability of all the clonotypes at a given rank is
the average of all the individual relative stabilities of clonotypes
at that rank. Thus, clonotypes with rank lower than six in the
pooled repertoire that consists of six time points cannot be stable.
To assess the relationship between clonotype distributional
frequency and the estimates of temporal stability we used
correlation analysis and provided correlation coefficients, R and
coefficients of determination, R2.
While our data sets are of similar size, the number of
observations (M), and clonotypes (N) can vary, we used a
number of normalization procedures. Normalized rank can be
used for plotting the relation to normalized rank frequency or to
average relative stability. We normalize each ln-rank by dividing
the log-transformed values of Rmax; the latter representing the
largest rank possible. The extreme values in this case are 0 for
ln 1
lnRmax
and 1 for lnRmax
lnRmax
. For rank frequency, we normalize
the ln-rank frequency by dividing by the highest frequency
component which is when the rank = 1 (singleton clonotypes =
Ns). This spreads the data from one to zero, with one reflecting
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the contribution of the highly abundant singleton clonotypes,
resulting from lnNs
lnNs
= 1, and the frequency of the highest ranking






normalization procedure works best for comparison of power
law-like distributions. The normalized rank and rank frequency
relationships were formally tested using an anchored power-
law regression model, in which we regressed normalized ln-rank
frequency y against normalized ln-rank x as follows: y = 1 – (1
– (1 – x)u)v, where u and v are the power-law parameters that
govern the relationship curvature.
The data collected here represent clonotype numbers and
frequencies that were a function of the cDNA input used to
generate the amplicons used for the subsequent Roche GS-
FLX Genome Sequencer analysis. Increasing or decreasing the
concentration of cDNA increase or decreases the number of
clonotypes identified and the frequency of the low ranking
clonotypes as well as the maximum rank. Data were analyzed
usingMicrosoft Excel and RStudio. Our definition of “clonotype”
as used here has been qualified above.
The clonotype datasets generated and analyzed here are
available as Supplemental Data 1 as is the approach for deriving
the CDR3 nucleotide sequence from the clonotype names
(Supplemental Figure 1).
RESULTS
Role of Clonotype Rank as a Proxy
for Selection
A repertoire is composed of clonotypes, which are defined by
the clonal rearrangement of the receptor genes. As the clonotype
is peripherally selected it expands and thus has an increased
frequency within the repertoire. The frequency is measured by
the number of observations after a controlled amplification of
the receptor genes or transcripts. As long as the frequency is
attributed to the entity “clonotype,” the analysis of the repertoire
is limited to counting the clonotypes and/or some characteristic
thereof. A higher level of analysis is obtained if the repertoire
is described by a frequency of frequencies. In this approach,
the absolute or relative measurement of the clonotype defines
the rank of the clonotype. Thus, the repertoire (a pathogen-
specific ecosystem) can be viewed as a collection of clonotypes
(species) whose previous successful selection defines their rank
(abundance).Wewill be sampling this system indirectly, from the
circulation, and our samples will represent a small portion of the
overall repertoire. Therefore, our quantitation will be relative but
should reflect proper relationships as long as we do not skew the
counting process by the methodology used to amplify the signal.
The methods section describes the precautions we take to be in
the proper relation of starting cDNA and amplification cycles.
As we have previously described (13, 17, 18, 27), the rank-
based description of the repertoire shows that the highest
frequency of responding clonotypes is that of clonotypes
representing the lowest rank, i.e., those measured once. A log-
log transformation of the rank vs. rank-frequency data shows a
two-component plot with one component decreasing in a linear
manner, and the second consisting of a number of mostly single
clonotypes at very high ranks. The first component is indicative
of a power law-like distribution fitting the equation y = axb. The
exponent, b, describes the distribution of the rank frequency of
the clonotypes in the repertoire as it descends from the lowest to
highest ranks. In the log transformation of the above equation,
log y = b∗log x + a, parameter b represents the slope of the
data which is approximately linear. Parameter a represents the
proportion of clonotypes that constitute the lowest rank, and is
the y intercept of the line.
The thymus produces an initial repertoire that is relatively
uniform, with skewing due to increased probability of certain
aspects of the rearrangement mechanism (29) along with
the limited expansion after β-selection (26, 30). Our initial
description of how a power law-like distribution may arise
from an initially uniform distribution was very focused on the
TCR but actually represents a general phenomenon. With a
random uniform distribution of receptors, a measure of affinity
for a particular ligand will be normally distributed (31). A left-
censored normally distributed distribution represents positive
affinity with the maximum number of receptors being neutral
and a small number representing the high affinity. An example
for ∼4,000 clonotypes representing a left-censored distribution
is shown in Figure 1A (filled circles). All that needs to be done
is to postulate that affinity will correlate with response, which
includes cell division (32, 33). This can be thought of as a
reward function for the lymphocyte network. A reward function
resulting in 12 divisions (3–4 days) for the highest affinity (212
∼ 8,000 cells) and no divisions, but survival, for neutral affinity,
is shown (Figure 1A, open circles). The resultant repertoire
distribution (Figure 1B) shows a power law-like distribution.
Hence, an initial uniform distribution of clonotypes that display
a normal distribution with respect to affinity to ligand can give
rise to distribution with power law-like characteristics on the
basis of selective cell division, with the clonotype rank describing
the selection.
An important characteristic of a power law-like distribution is
that it is scale free. From a sampling perspective, this means that
doubling the amount of cells, will generate the same distribution
pattern with some of the cells that were observed once now being
observed twice, some that were observed twice now three times,
etc. If we only use half the cells, we lose some singletons, some
doubletons become singletons, etc. However, as long as the PCR
cycle number is decreased, the distribution remains the same and
is still representative. Without compensating the cycle number,
the data becomes skewed owing to over-amplification.
However, the immune response is also characterized by a
reduction of the expanded population after pathogen clearance,
which we have modeled as a birth-death process (20, 21).
The birth-death model more closely approximates our actual
observations. Of course, even the birth-death model does not
incorporate other factors like signaling thresholds, nor does it
address possible probabilistic approaches to cell division which
would require counting numbers of APC-T cell interaction, or
numbers of exposures. However, it is clearly a guiding principle
for arriving at a power law-like distribution from a uniform
normal distribution and shows the usefulness of approaching
repertoires using clonotype rank as a descriptor.
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R = - 0.99
FIGURE 1 | Power law-like distribution as a result of a reward function applied
to a starting clonotype population normally distributed with respect to affinity.
(A) The neutral to positive affinity portion of a normally distributed (σ = 0.14)
population of clonotypes is shown as filled circles. The corresponding reward
function resulting in the number of cell divisions is shown as empty circles.
Since the division process is discrete, a range of affinities can fall within a
particular doubling threshold. The reward function was set for a maximum of
12 divisions in equally distributed steps across the affinity spectrum. (B) The
reward was applied to the number of cells at each affinity increment and the
rank frequency of the resulting distribution calculated and plotted.
Rank-Frequency Distribution of Adult BV19
Utilizing CD8 T Cells
Our initial analysis of complex repertoires utilized the recall
response to influenza M158−66. Circulating CD8T cells
expressing the BV19 TCR represent the next higher level of
repertoire structure that encompasses this response. Analyzing
the BV19 repertoire would represent a generalization of our
findings. Indeed, an initial HTS analysis of BV19 CD8 TCR
from an adult subject showed a similar complex clonotypic
distribution to our previous recall data (19). Here we have
added the HTS analysis of pooled circulating BV19 CD8T cell
repertoires from four middle-aged adult subjects, mA1 to mA4.
The subject age and average sampling data are given in Table 1
(ex vivo HTS panel). Sample collection relative to the timing of
the first sampling is provided in Supplemental Table 1. In all
cases the pooling was of samples collected on average every 2
months, and the period of elapsed time between first and last
samples is approximately a year and a half. Standard repertoire
measures and characteristics for the pooled repertoires,
described in the Method section, are provided in the top panel
of Supplemental Table 2. The data from the five subjects
differed slightly in depth of analysis at the level of number of
observations, M. We also provide a summary of the repertoire
measures and characteristics for the individual samples in the
form of average values and deviations in the bottom panel of
Supplemental Table 2. As might be expected, there was some
variability in the measures obtained at the different time points
for all subjects but overall the values are comparable.
The rank frequency analysis for the pooled repertoire data
for all five subjects is shown in Figure 2A. The rank frequency
plots are very similar, and each has a power law like component
and a second high-ranking component which are demarcated at
rank ln 5 by a vertical line. Thus, ln 5 corresponds to the critical
point dividing the power law-like component(s) from the high-
ranking component. As noted previously (19), the power law-like
component appears to have two parts which are divided at ∼ ln
2. It should be pointed out that the data were generated without
using unique molecular identifiers (28) and it is very likely that
the two parts of the power law-like component observed in the
rank-frequency analysis is a function of sample concentration
to amplification cycle ratios. All five BV19 repertoires show
a similar clonotype distributional frequency profile with the
average correlation coefficient of−0.83 (R=−0.83± 0.03 andR2
= 0.68± 0.05). Individual R and R2 values are shown in Table 2,
in the section labeled “Rank vs. Rank Frequency Figure 2A.”
Clonotype Stability
Clonotypes in a pooled repertoire have a measure describing the
number of times they are present among the different sample
times, which can define the stability of the clonotypes in the
repertoire. This, measure is defined by the number of time points
(increments) at which the clonotype was observed.With a pooled
repertoire representing a number of distinct sampling times, a
clonotype that is observed once is considered unstable and one
observed at all times is considered stable. The temporal stability
of the pooled repertoire is defined by the number or relative
frequency of the clonotypes at each stability increment. The
repertoire temporal stability data is shown for all five subjects in
Figure 2B. The number of possible observation times (stability)
is on the x-axis. The number of clonotypes at each stability
increment is plotted on the y-axis using a logarithmic scale and
the percentage of clonotypes observed only once is shown above
the first bar. Most clonotypes are only observed once, indicating
their temporal instability.
The repertoire stability is characterized by a decreasing
frequency of clonotypes at higher stability increments. This was
examined in more detail by plotting the natural logarithms of
stability and clonotype frequency at each stability increment
(Figure 2C) which showed that this relation is also power
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FIGURE 2 | Time series analysis of the ex vivo BV19 repertoires of five adult subjects using high throughput sequencing. (A) Natural log-transformed clonotype ranks
vs. rank frequency. The inflection point in the graph is identified by vertical dotted lines at ln-rank 5. (B) Repertoire stability data. The absolute number of clonotypes is
shown for each stability increment. The clonotype count (y-axis) is on a log10 scale. The percentage of clonotypes observed at one time is shown above the bar
graph. (C) The natural log-transformation of the data in panel B. (D) The log-transformed average stability is plotted as a function of ln-rank. The vertical lines show the
two rank components defined by their inflection points of the distributional curve. The R values, where shown, describe the coefficient of correlation.
law-like. The value of the negative correlation between ln
stability and ln number of clonotypes (R = −0.95 ± 0.02
and R2 = 0.91 ± 0.03) is very similar for all the subjects,
irrespective of the variation in the numbers of times sampled or
number of observations and clonotypes between the individuals.
This similarity implies that we are defining a fundamental
characteristic of the repertoire. The R and R2 values associated
with Figure 2C and the means and standard deviation for these
data sets are given in Table 2: Stability vs. Number of Clonotypes.
It was of interest to examine the relation of the stability
measure with relation to clonotype rank. This is done by
calculating the average stability for all the clonotypes observed
at a particular rank. Figure 2D shows that stability increases as
the rank increases. The R values are shown for each subject and
the average of R = 0.80 ± 0.02. The R2 values are provided in
Table 2 section “Figure 2D” and the average of R2 = 0.65± 0.03.
For all five subjects, there is a rank after which the clonotypes are
all stable although the extent of this fraction can vary from subject
to subject.
Comparison of Clonotype Rank Frequency
and Stability as a Function of Rank
Examining Figures 2A,D indicates that there may be a direct
relation between rank-frequency and rank-stability. This relation
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TABLE 2 | Coefficients of correlation (R) and determination (R2) between: (1) rank and rank frequency, (2) stability and number of clonotypes, and (3) rank and average
stability for each individual within the study cohorts in reference to Figure 2.
Rank vs. rank frequency Stability vs. number of clonotypes Rank vs. average stability
R R2 R R2 R R2
Subject ID Figure 2A Figure 2C Figure 2D
oA1 −0.841 0.708 −0.945 0.893 0.816 0.665
mA1 −0.788 0.621 −0.925 0.855 0.822 0.676
mA2 −0.862 0.744 −0.959 0.921 0.774 0.599
mA3 −0.831 0.691 −0.973 0.946 0.811 0.658
mA4 −0.808 0.653 −0.959 0.92 0.796 0.633
Average§ −0.83 ± 0.03 0.68 ± −0.05 −0.95 ± 0.02 0.91 ± 0.03 0.80 ± 0.02 0.65 ± 0.03
§ Indicates mean ± standard deviation.
was analyzed by generating a measure of normalized rank
and plotting either normalized rank frequency (Figure 3A)
or normalized average stability (Figure 3B) as a function of
normalized rank. The normalized rank frequency plots for each
subject differed slightly with respect to slope and inflection
point between the second and third component. The stability
plots showed the same relative differences resulting in a striking
symmetry between the two data sets. Stability is a function of
increasing rank which is inversely associated with frequency
of clonotypes at that rank. There is some noise, defined as a
spread of a particular stability level over a number of ranks,
in the stability data. The significance of the noise, which is
most apparent in the data from subject mA2, is still not
clear. Overall, the data show that clonotype stability together
with clonotype distribution are integral properties of overall
repertoire complexity.
The stability measures and characteristics of the five pooled
repertoires are provided in Supplemental Table 2 and Figure 2B.
While the fraction of stable clonotypes varies between 0.004 and
0.021 (average∼0.01) this small fraction of stable clonotypes can
represent an average of ∼0.38 of the observations (proportion
of stable clonotypes, MstM ). Thus, a large part of the circulating
BV19 CD8T cells are composed of a small number of very
stable clonotypes.
The results of these ex vivo analyses of adult CD8 repertoires
show that there is a small percentage of clonotypes representing
a large percentage of T cells that are represented in the
circulation at all times, which is compatible with a stable
circulating depot of cells. This also would explain the different
distribution of the second rank-frequency component. For this
component, rank is not just a function of previous expansion but
also of accessibility.
Stability of the M158−66 Recall Repertoire in
Subjects Representing Three Age Cohorts
The BV19 data reflects a comprehensive description of a large
number of clonotypes of unknown specificity at a particularly
point in development. We hypothesized that the complexity
observed in the adults is part of a dynamic process of
evolution and devolution over a lifetime (21). To examine
this hypothesis, we focused on the memory component as
defined by recall of the M158−66-specific CD8 BV19T cell
repertoire from samples obtained from child, middle-aged,
and older adult cohorts (Table 1). The repertoire consists of
the canonical clonotypes whose receptor encodes Arg and Ser
in the correct location of the non-germline-encoded portion
of the receptor. Because we are focusing on stability as a
steady-state phenomenon, time points were chosen for the
recall analysis to avoid including samples after a suspected
or proven influenza exposure. Immunization with trivalent flu
vaccine does not appear to have an effect on the M158−66
repertoire, which is not unexpected as it is not part of
the vaccine.
We have previously analyzed single time points from two adult
cohorts representing middle-aged and older individuals (18).
These both show similar two component rank-frequency data
that differ in the proportion of singleton clonotypes, lower for the
older cohort, and position of critical point between components,
left-shifted in older adults.
Here we present the analysis of the clonotype stability of
some of the same individuals as well as others in the same
age cohort and we have also provided data from a child
cohort. The individual sampling data for the three age cohorts
are provided in Table 1. The measures and characteristics
of the recall repertories of the subjects in each of the
three cohorts is provided in Supplemental Table 3 for the
child cohort, Supplemental Table 4 for the middle-age, and
Supplemental Table 5 for the older adult cohorts. Average values
of the measures and characteristics for each cohort is provided in
Supplementary Table 6.
To help visualize the expected and actual outcomes of the
stability analysis, the data are plotted as the natural log of
stability, and the lower x-axis is annotated in terms of the stability
increment, counting the number of sampling times in each
analysis. The actual ln values are shown on the upper axis. A
tick mark without an associated data marker represents a missing
value. The BV19 RS L11 recall repertoire shows a decreased
frequency of clonotypes as the stability increment increases. The
regression analysis shows an excellent linear fit (R = −0.98
± 0.01 and R2 = 0.96 ± 0.03), and therefore the relationship
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FIGURE 3 | Relationship between normalized clonotype rank and either (A)
normalized rank frequency or (B) normalized average stability for five adult
subjects. Subject data is identified by different marker colors as shown in the
insert of (A).
between stability and clonotype frequency can be described as
power law-like (Figure 4A and Panel 1 in Table 3). Importantly,
none of the five child subject repertoires had M158−66-specific
clonotypes that were stable; i.e., observed at all times sampled.
The missing values represent the highest stability increments
and the number of missing values varies from subject to subject.
These data indicate that the clonotypes involved in the response
are starting to show signs of increasing stability but have not yet
generated a completely stable clonotypic subset of the repertoire.
Even though complete stability is not attained, the stability data
is described as a power law-like distribution, as was observed for
the BV19 ex vivo adult data.
Stability of the M158−66-specific clonotypes in middle aged-
subjects (Figure 4B) was similar to the BV19 ex vivo repertoire
data, of which these clonotypes are a subset. There is power law
like distribution with an increase in frequency at higher stability
increments. The regression analysis shows an excellent fit of the
data and a high overall correlation (R = −0.89 ± 0.07, Panel
2 in Table 3).
The stability data of older subjects is shown in Figure 4C
and Panel 3 in Table 3. The data for oA2 is most similar to the
middle-aged data. However, there are two-time point increments,
4 and 6, for which there are no values, indicating a loss of
stability. Subject oA1 and oA3 can be considered to have a
child-like pattern, in that there are no clonotypes present at the
highest three or four stability increments. Subject oA4, oA5, and
oA6 show an intermediate pattern in which there is a reversion
to a child-like pattern, with the maintenance of some of the
high stability pool of clonotypes. Thus, the older adult data
indicates an interesting interrupted pattern in the clonotype
stability pattern as would be expected from senescence of
independent pools.
Comparison of Recall Clonotype Rank
Frequency and Stability as a Function
of Age
Rather than trying to compare 15 panels each of rank frequency
and rank stability data analyzed as five- (child), four- (middle-
aged), and six- (older adult) clusters, we generated a cohort
specific summary for rank vs. rank frequency (Figure 5A) and
for rank vs. stability (Figure 5B). The recall repertoire data was
generated by binning the normalized rank values of all subjects
in a cohort in increments of 0.05 and averaging the individual
rank values as well as the corresponding frequency or stability
values associated with each bin. The data were fitted as anchored
regressions, defined by parameters u and v using the formula, y=
1 – (1 – (1 – x)u)v. The parameter u controls the concave aspect of
the curve, whereas v reflects how evenly points are distributed on
the curve. With both u and v at unity, the data would constitute a
straight line between (1,0) and (0,1).
For the child cohort, the parameter pair of u = 1.735 and
v = 0.855 is indicative of a slight concave deviation from a
45◦ linear slope (Figure 5A, red circles). For the adult cohort,
the pair of u = 3.3 and v = 1.25 is characteristic of a steep
curvature; and for older cohort the pair of u = 5.8 and v =
0.9 is characteristic for a steady slope for the low-frequency
component and a very steep curvature for a high-ranking
component (Figure 5A). The values for v for the child cohort
resemble values for the older adult cohort indicating similar
properties of the low-frequency component in the repertoire
distribution. The v value is indicative of the regularity of the
rank values along the curvature; with the child cohort showing a
relatively even spread, whereas the older adult values are densest
in the high-frequency portion of the curve. The two adult cohort
datasets show very similar patterns of distributional complexity
to those we described in a previous study (18) using samples only
collected at one time.
The normalized average stability values for the three cohorts
(Figure 5B) shows that for themiddle-aged adult cohort, the high
ranking clonotypes are consistently and strongly associated with
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FIGURE 4 | Repertoire stability data from M158−66 specific recall analyses of (A) five child subjects, (B) four middle-aged adult subjects, and (C) of six older adult
subjects. Repertoire stability data is shown as the natural log-transformed stability increment vs. number of clonotypes at that stability. The lower x-axis indicates
absolute values of stability increments. The upper x-axis is demarcated in terms of the ln of the stability increments. Lack of a datapoint at a stability increment
represents a missing value. Subject identifiers are shown above each set of panels. The R values represent coefficients of correlation for each dataset.
maximum stability (R2 = 0.91). The child cohort is characterized
by lower stability with none of the highest ranking clonotypes
were observed at all times examined (R2 = 0.85). The older adult
cohort data (blue diamonds) shows a similar trendline to that of
the child. However, the spread of stability values is quite wide at
the high ranks (R2= 0.71). This heterogeneity is due to individual
differences within the cohort with some subjects having stable
clonotypes at higher ranks while others do not (Figure 4). This
is linked to the higher density of values at higher ranks in this
cohort noted above. In spite of this higher density of high ranking
clonotypes overall stability is lost indicating that in this cohort the
relation between stability and rank is broken.
The recall data provide a focused examination of antigen-
specific repertoire characteristics, but also reflect the nature of the
functional definition of specificity. The data are summation of the
complex distribution in the PBMC as well as the in vitro survival
and growth potential of these cells. The latter may vary based on
how many previous divisions the cells had already undergone,
or requirements for costimulation that are not being met in
the culture conditions. While the specific nature of the recall
measurements may come at the price of additional heterogeneity,
the stability and complexity measures show a definite change of a
peptide-specific repertoire with age.
DISCUSSION
The analysis of CD8T cell repertoire evolution presented
here defines a new measurable characteristic of the circulating
repertoire, clonotype stability, and shows that stable clonotypes
make up a sizable fraction of the mature circulating CD8
BV19 repertoire. The symmetrical relation between the stability
and rank frequency provides an explanation for the previously
noted division of clonotype rank frequency into at least two
distributional components when examined by rank frequency
analysis. We propose that the first distributional component
representing a power law-like distribution in the circulation,
represents a sample of the repertoire that is sequestered in
depots (bone marrow, spleen, LN, and tissues). The role of
lymphocytes in the circulation has always been postulated to
involve purposeful movement from memory depots to lymphoid
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TABLE 3 | Coefficients of correlation (R) and determination (R2) between stability
and number of clonotypes for each individual within the study cohorts in reference
to Figure 4.








Average§ −0.98 ± 0.01 0.96 ± 0.03





Average −0.89 ± 0.07 0.80 ± 0.12







Average −0.89 ± 0.09 0.80 ± 0.16
§ Indicates mean ± standard deviation.
organs or affected tissues/organs (3, 9, 10). Under normal
conditions, only a small portion of circulating CD8 lymphocytes
have markers indicating very recent activation (34), most express
the inhibitory receptor CD31 (35), hence it is highly likely
that they are being released from depots as part of a sentinel
process and not in response to an exposure. We assume that
the sequestered mature memory repertoire also shows a power
law-like distribution. The first component would represent
a proportion of the tissue/depot resident repertoire that has
entered the circulation. The probability of observing the same
clonotype at multiple times would be function of the frequency of
that clonotype in the repertoire (its rank) and of the circulatory
dwell time.
The second frequency component is over-selected in the
analysis process because the continuous presence of these
clonotypes in the circulation results in their being sampled
at an entirely different frequency than that of the clonotypes
in the more dynamic component. Clonotypes in the more
stable component have been the focus of previous longitudinal
HTS analyses (36, 37). With the presence of two components,
examining pooled repertoires would quickly establish the stable
portion but would also begin to describe the hidden portion












































































Predicted Normalized Rank 
Children (C):
u = 1.735  and  v = 0.855
Middle-Aged Adults (mA):
u = 3.3  and  v = 1.25
Older Adults (oA):
u = 5.8  and  v = 0.9
FIGURE 5 | Relationship between estimated clonotype rank, rank frequency
and stability of recall BV19 repertoires from child (filled circles), middle-aged
adult (open circles) and older adult (diamonds) cohorts. (A) Predicted
normalized rank vs. predicted normalized rank frequency. (B) Predicted
normalized rank vs. predicted normalized average stability. Anchored
regression lines for children (orange) and middle-aged adults (green) and older
adults (blue) are shown.
law-like component. Ignoring or filtering out this dynamic
component would provide an incomplete description of the
entire repertoire.
Our data does not rule out the possibility of a second
more highly expanding component that could be generated
in the initial immune response. It is possible that T cell
subsets each have their own reward function as described in
Figure 1. There is some evidence for this possibility in the
child cohort data which shows a hint of an unstable second
component (Figure 5).
Our focus on canonical BV19 RS-encoding CDR3 length 11
clonotypes, does not rule out the presence of other clonotypes
in children, which are supplanted by the canonical clonotypes.
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FIGURE 6 | Schematic of the evolution and devolution of repertoire complexity. The y-axis represents complexity entailing both clonotype distribution (blue) and
stability (orange). The extent of the complexity is representative and reflects maximum distributional and stability measures at maturity.
T cells responding to M158−66 have been identified in cord-
blood and blood from HLA-A2 infants, but these are no longer
observed in adults (38, 39).
A circulating pool of stable clonotypes could result from the
expansion of important clonotypes beyond the carrying capacity
of the memory depots or tissues. We propose it represents
maturation stage that maintains a quick response to recurring
pathogens. This maintenance would be solidified over time
as part of a robust system. It should be pointed out that
a circulating depot makes sense for mature effector cells as
compared to helper/regulatory T cells. Thus, it will be interesting
to determine if cytotoxic CD4 cells which are often observed
in mature individuals (40) also have a circulating component.
It will also be interesting to define further characteristics of
the stable repertoire in terms of the type of pathogen involved,
whether chronic or recurring, the tissue dispersion of the
pathogen, the degree of cross-reactivity of the T cells, and
their surface phenotypes.
Reflection on the nature of amature robustmemory repertoire
as well as our dynamic data indicate the importance of repertoire
stability. Examining stability as defined here raises important
issues about time and sampling, which will require further study.
The BV19 ex vivo data are representative of short-term stability
in that the elapsed time was about a year and a half. The recall
data comprised a slightly longer term (Supplemental Table 1).
The cohort comparisons describe the system over longer elapsed
times, but these are not longitudinal. The longer the time
span measured longitudinally the more confidence one has in
defining a truly stable population. The key points in repertoire
maturation are defining when an individual establishes a stable
repertoire and when it starts to decay. These measurements
are easy for the second distributional component, but more
difficult for the first. In addition to frequency of timing,
examination of multiple samples per time point would be
useful to determine stability as defined by the sampling of a
power-law like distribution in comparison to the effect of time.
We expect that a careful examination of samples from older
children and young adults will show evidence both for a steady
buildup of clonotypes that will form the stable circulating pool
as well as the transient clonotypes reflecting release from the
repertoire depots.
The generation of a stable circulating component is a
function of the temporal evolution of the immune system.
Stable influenza-specific clonotypes were not observed in the
child cohort, appeared to be well-established in middle-aged
subjects, and were starting to degrade in older subjects. While
our data are focused on one V family and one immune
response, the self-similar nature of the system makes it likely
that the observed phenomena will carry over to most CD8T cells
and responses.
We present a general schematic of this temporal evolution
process for CD8 cells (Figure 6) incorporating frequency and
stability as a function of rank and moving left to right on a
time axis and bottom to top on a complexity axis. A sample
of the initial naïve repertoire (lower left panel) would be
relatively uniform (mostly rank of one). It would represent
a low level of complexity (although high abundance). We
have previously examined the frequency of BV19, RS-encoding
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clonotypes in CD8 single-positive thymocytes as a proxy for the
naïve repertoire, and have shown this to be the case, with a minor
skewing due to the function of a rearrangement mechanism
involving long P nucleotide addition from the J2-7 region
(29). Upon first contacts with influenza the repertoire would
show the expansion (increased rank) of selected clonotypes
and an increase in stability relative to the frequency of the
clonotype in the actual memory depots (second panel). With
increasing number of exposures, the repertoire distribution
becomes complex but does not develop the stable circulating
component until maturity, which would represent the highest
level of complexity (middle panel). With time and more
exposures, the repertoires become more heterogeneous in their
characteristics and both components of the repertoire can
devolve independently.
The heterogeneity of an aging immune system is only
hinted at in Figure 6. We have previously shown that even
in middle-age individuals, repertoire changes in a 5- to 10-
year time scale, involve a loss of the canonical BV19 RS
clonotypes and an increase in other clonotypes utilized in
recall responses (41). Our recall data of the older cohort here
has been restricted to canonical clonotypes to aid comparison
between cohorts. However, we observe a large increase in non-
canonical clonotypes in recall responses from older individuals
(in preparation). Our previous modeling of the changes between
middle- and older-aged adult cohorts indicates an age-related
loss of clonotypes based on rank (18). Re-exposure to the
virus continues throughout an individual lifetime making it
likely that the rank-based loss of complexity observed in the
descending part of Figure 6 is due to such exposures (41).
We propose that during the devolution of the repertoire
there is an exposure-based loss of clonotypes, compensated by
replacement with next best clonotypes, followed by the loss
of the compensatory clonotypes, resulting in a tipping point
synonymous with immunosenescence. Measuring the individual
rate of loss from recurring exposures should provide a warning
of immunosenescence and approaching criticality.
Our results describe a dynamic process of system development
and aging, with increasing distributional complexity, leading
to a stable circulating component, followed by loss of both
complexity and stability. Along with a better understanding of
the general aspects of memory generation, maintenance and
decline, this study poses some fundamental questions of how
well we can potentially measure T cell memory in humans
and/or how complete this knowledge could be. We still have
no answers to how frequently and for how long we should
measure a repertoire in order to define its stability. Could
a routine blood sample be a representative sample of the
circulating pool? And if not, what is the alternative. We expect
that stability will be affected by pathogen exposure, hence
our care in trying to eliminate that aspect from the current
analysis. But what degree of departure from stability would
be considered as a measure of resilience or decline? These
emergent questions are immediately important in thinking about
circulating cells as a source for immunomodulatory therapy and
they shape a new direction in quantification of the way immune
memory evolves.
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Supplemental Figure 1 | Clonotype naming algorithm. The name is meant to be
available for computation. It consists of the concatenation of the NDN amino acids
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in single letter code, in upper case, proceeded and followed by the last amino acid
completely V-encoded and the first completely J encoded in lower case. A period
separates the amino acids from the NDN encoding. This is followed by the V
identifier which starts with B or A for beta or alpha followed by the family number,
the letter “s” and the subfamily identifier. Next come the J-region identification,
with again A for alpha, B for beta. Followed by the J cluster and locus position
identifier, with no separator. The name provides the information as to the key
diversity element that distinguishes this V-J combination from any other using the
exact same V and J. To regenerate the CDR3 nucleotide sequence from the name
one moves backwards through the naming algorithm. (A) We start with the
clonotype name of the most frequent clonotype in the C1 recall dataset. The key
data are colored to identify their content. (B) The genomic sequences of the V and
J are lined up so that there are L codons between the Cys and Phe Gly. The
Amino acids of the NDN (upper case) are aligned and the nucleotide sequence of
each is inserted. (C) The nucleotide sequence is assembled by overlapping the V,
NDN, and J sequences with the V and J lower case base pairs being used first
until they no longer match the NDN codons. The germline contribution to the
CDR3 is underlined in the sequences provided in (B). This provides the best
estimate of the rearrangement point. (D) The subset of the genetic code table
needed for converting the a.a. name and encoding to nucleotide sequence in step
B. The period in the name provides a visual break, but is also useful to FIND the
start of the codon ID string. The NDN region can be substringed by starting at
position 2 and stopping before the period. The NDN length can be determined
from the same procedure. The “L” provides a visual break between the J and
CDR3 length numerical identification. The letter “S” was used at one time to
separate the V family and Subfamily identification. Current nomenclature uses a
bar. Current nomenclature does not require a TRBV19-1 since there is no 19-2
locus. However we include the subfamily tag to maintain spacing in the name. All
lengths take two characters, hence a CDR3 length of 9 amino acids is L09. Alleles
are neglected. There are no V alleles reported yet in the region distal to the Cys.
There are two J-region alleles, one is silent, but the one in J2-7 changes the F in
the FG to V. The nomenclature could be modified to include allele identification but
it would be wise to avoid the current nomenclature use of an asterisk as it is
usually interpreted as a wild card and requires additional handling if the name is
being used in a computation.
Supplemental Table 1 | Time-map of peripheral blood collection for each subject
relative to first sampling.
Supplemental Table 2 | Summary of high-throughput sequencing data for the
adult cohort.
Supplemental Table 3 | Measures and characteristics of the M158−66-specific
recall repertoires for the child cohort.
Supplemental Table 4 | Measures and characteristics of the M158−66-specific
recall repertoires for the middle-aged adult cohort.
Supplemental Table 5 | Measures and characteristics of the M158−66-specific
recall repertoires for the older adult cohort.
Supplemental Table 6 | Summary of M158−66-specific recall BV19 repertoire
measures and characteristics for the child, middle-aged, and older adult cohorts.
Supplemental Data 1 | The clonotype names, counts, and stability values for all
the analyses presented in this manuscript are provided.
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